Single-arm, phase 2 study of regorafenib plus nivolumab in patients with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC).
暂无分享，去创建一个
N. Sharma | M. Fakih | J. Bendell | D. Cosgrove | Ying A. Wang | A. Cohn | L. Garbo | K. Raghav | D. Chang | M. Herpers | S. Ravimohan | D. D’Adamo | V. Potter | Timothy K. Huyck | C. Oliveira | A. Paulson | J. Fiorillo | T. Larson | Sabine Coppieters | Carolina Soares Viana de Oliveira